What Becton Dickinson and Co's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 4 | 21 |
| Total trades | 8 | 77 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 43,278 | 207,062 |
| Disposed | 47,196 | 107,649 |
| Net activity | −3,918 | +99,413 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Feld Michael | EVP, Chief Revenue Officer | Sep 28 | Open-market sale · S | −76 | $183.70 | −$14K | 19,644 |
| Roque Vitor | EVP & Chief Financial Officer | Sep 02 | Withheld — tax / exercise cost · F | −190 | — | — | 8,041 |
| Feld Michael | EVP, Chief Revenue Officer | Aug 26 | Open-market sale · S | −165 | $188.49 | −$31.1K | 19,720 |
| Feld Michael | EVP, Chief Revenue Officer | Aug 20 | Withheld — tax / exercise cost · F | −1,049 | — | — | 19,885 |
| Polen Thomas E Jr | Chairman, CEO and President | Aug 13 | Open-market sale · S | −4,152 | $185.00 | −$768K | 110,163 |
| Polen Thomas E Jr | Chairman, CEO and President | Aug 13 | Disposition to Issuer · D | −39,126 | $185.00 | −$7.24M | 114,315 |
| Polen Thomas E Jr | Chairman, CEO and President | Aug 13 | Exercise / conversion · M | +43,278 | $167.25 | +$7.24M | 153,441 |
| Goette Roland | EVP and President, EMEA | Aug 11 | Open-market sale · S | −2,438 | $180.84 | −$441K | 14,856 |
| Feld Michael | EVP, Chief Revenue Officer | Jul 27 | Open-market sale · S | −75 | $157.13 | −$11.8K | 20,934 |
| Muhsin Bilal | EVP & President Connected Care | Jul 02 | Withheld — tax / exercise cost · F | −1,935 | — | — | 41,359 |
| Muhsin Bilal | EVP & President Connected Care | Jul 01 | Grant / award · A | +14,342 | — | — | 43,294 |
| Feld Michael | EVP, Chief Revenue Officer | Jun 26 | Open-market sale · S | −75 | $152.80 | −$11.5K | 21,009 |
| Garrison Michael David | EVP & Pres Med.Essntl&BioPharm | Jun 24 | Open-market sale · S | −1,100 | $145.66 | −$160K | 13,172 |
| Garrison Michael David | EVP & Pres Med.Essntl&BioPharm | Jun 10 | Open-market sale · S | −1,100 | $151.48 | −$167K | 14,272 |
| Menziuso Peter | EVP and President, BDI | Jun 01 | Grant / award · A | +14,258 | — | — | 14,258 |
| Polen Thomas E Jr | Chairman, CEO and President | Jun 01 | Open-market sale · S | −2,764 | $146.35 | −$405K | 110,163 |
| Polen Thomas E Jr | Chairman, CEO and President | Jun 01 | Disposition to Issuer · D | −17,445 | $146.15 | −$2.55M | 108,235 |
| Polen Thomas E Jr | Chairman, CEO and President | Jun 01 | Exercise / conversion · M | +20,209 | $126.16 | +$2.55M | 125,680 |
| Feld Michael | EVP, Chief Revenue Officer | May 26 | Open-market sale · S | −75 | $147.35 | −$11.1K | 21,084 |
| Roque Vitor | EVP & Chief Financial Officer | May 07 | Grant / award · A | +1,721 | — | — | 8,231 |
Loading...
